KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Income from Continuing Operations (2016 - 2025)

Pacira BioSciences has reported Income from Continuing Operations over the past 16 years, most recently at 1637000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1637000.0 for Q4 2025, down 89.79% from a year ago — trailing twelve months through Dec 2025 was 7034000.0 (up 107.07% YoY), and the annual figure for FY2025 was 7034000.0, up 107.07%.
  • Income from Continuing Operations for Q4 2025 was 1637000.0 at Pacira BioSciences, down from 5432000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PCRX hit a ceiling of 25763000.0 in Q2 2023 and a floor of 143466000.0 in Q3 2024.
  • Median Income from Continuing Operations over the past 5 years was 7903500.0 (2022), compared with a mean of 363650.0.
  • Biggest five-year swings in Income from Continuing Operations: surged 1666.81% in 2023 and later tumbled 1421.29% in 2024.
  • Pacira BioSciences' Income from Continuing Operations stood at 5130000.0 in 2021, then crashed by 96.92% to 10102000.0 in 2022, then skyrocketed by 346.19% to 24870000.0 in 2023, then plummeted by 35.5% to 16041000.0 in 2024, then plummeted by 89.79% to 1637000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1637000.0 (Q4 2025), 5432000.0 (Q3 2025), and 4847000.0 (Q2 2025) per Business Quant data.